US Patent Issued to ACADIA Pharmaceuticals on Dec. 9 for "Crystalline forms of trofinetide" (American, Belgian Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,167, issued on Dec. 9, was assigned to ACADIA Pharmaceuticals Inc. (San Diego).

"Crystalline forms of trofinetide" was invented by Matthew Peterson (San Diego), Marlon Carlos (Glendale, Ariz.), Martin Bernard Catherine Bousmanne (Woluwe Saint-Lambert, Belgium), Cecilia Betti (Brussels), David T. Jonaitis (Brookston, Ind.), Lisa M. Mccracken (Lafayette, Ind.) and Lisa M. Grove (Lafayette, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides crystalline forms of trofinetide and trofinetide hydrate, pharmaceutical compositions comprising crystalline forms of trofinetide and trofinetide hydrate, methods of making crystalline forms...